Holen Sie sich die Stockscreener-App
10.65
3.27%
-0.36
Handel nachbörslich:
10.65
Schlusskurs vom Vortag:
$11.01
Offen:
$11
24-Stunden-Volumen:
109.37K
Relative Volume:
0.59
Marktkapitalisierung:
$230.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.46M
KGV:
-25.25
EPS:
-0.4218
Netto-Cashflow:
$-34.00M
1W Leistung:
-5.00%
1M Leistung:
-6.17%
6M Leistung:
+159.76%
1J Leistung:
-36.04%
1-Tages-Spanne:
$10.49
$11.00
1-Wochen-Bereich:
$10.36
$11.23
52-Wochen-Spanne:
$3.35
$20.24
Contineum Therapeutics Inc Stock (CTNM) Company Profile
Firmenname
Contineum Therapeutics Inc
Sektor
Branche
Telefon
(858) 333-5280
Adresse
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO
Vergleichen Sie CTNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTNM
Contineum Therapeutics Inc
|
10.65 | 321.30M | 0 | -35.46M | -34.00M | -0.4218 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Contineum Therapeutics Inc Stock (CTNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-25 | Eingeleitet | Leerink Partners | Outperform |
| 2025-06-20 | Eingeleitet | William Blair | Outperform |
| 2024-10-22 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-30 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-04-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-30 | Eingeleitet | Stifel | Buy |
Alle ansehen
Contineum Therapeutics Inc Aktie (CTNM) Neueste Nachrichten
Live market analysis of Contineum Therapeutics Inc.Market Growth Report & Risk Managed Investment Entry Signals - newser.com
Why retail investors pile into Contineum Therapeutics Inc. stockWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com
Will Contineum Therapeutics Inc. stock benefit from automationMarket Trend Summary & Community Verified Trade Signals - newser.com
Why Contineum Therapeutics Inc. stock could see breakout soonJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
How Contineum Therapeutics Inc. stock reacts to inflationary pressuresWeekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com
Risk adjusted return profile for Contineum Therapeutics Inc. analyzedBond Market & Fast Entry Momentum Trade Alerts - newser.com
Real time social sentiment graph for Contineum Therapeutics Inc.July 2025 Momentum & Daily Chart Pattern Signals - newser.com
Contineum Therapeutics Inc. stock momentum explained2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
How Contineum Therapeutics Inc. stock compares to growth peersEntry Point & Scalable Portfolio Growth Ideas - newser.com
Volatility clustering patterns for Contineum Therapeutics Inc.July 2025 Breakouts & AI Optimized Trade Strategies - newser.com
Can Contineum Therapeutics Inc. stock outperform in 2025 bull market2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Is it time to cut losses on Contineum Therapeutics Inc.Earnings Growth Report & High Return Stock Watch Alerts - newser.com
What momentum shifts mean for Contineum Therapeutics Inc.2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com
Will Contineum Therapeutics Inc. stock split attract more investors2025 Major Catalysts & Consistent Profit Alerts - newser.com
Using Ichimoku Cloud for Contineum Therapeutics Inc. technicalsJuly 2025 Highlights & High Accuracy Investment Entry Signals - newser.com
Contineum Therapeutics (NASDAQ:CTNM) Issues Quarterly Earnings Results - MarketBeat
Using data models to predict Contineum Therapeutics Inc. stock movementPortfolio Gains Report & Daily Technical Stock Forecast Reports - newser.com
Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities - TipRanks
Is Contineum Therapeutics Inc. building a consolidation baseWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
What makes RF Acquisition Corp II stock price move sharply - newser.com
Building trade automation scripts for Contineum Therapeutics Inc.2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Contineum Therapeutics Reports Increased R&D Investment Amid Losses - TipRanks
Is Contineum Therapeutics Inc. stock attractive for growth ETFsJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Visual trend scoring systems applied to Contineum Therapeutics Inc.July 2025 Patterns & Daily Profit Maximizing Tips - newser.com
[10-Q] Contineum Therapeutics, Inc. Quarterly Earnings Report | CTNM SEC FilingForm 10-Q - Stock Titan
CTNM 8-K: Q3 2025 results press release furnished (Exhibit 99.1) - Stock Titan
Contineum Therapeutics Reports Third-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones - Business Wire
Finanzdaten der Contineum Therapeutics Inc-Aktie (CTNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):